Psychosocial impact of inclusion of HPV test on the management of women with atypical squamous cells of undetermined significance: a study within a randomised pragmatic trial in a middle-income country.

Objective: To assess the psychosocial impact of human papillomavirus (HPV) testing, colposcopy, and Pap-smear, as triage strategies after a Pap-smear with atypical squamous cells of undetermined significance (ASCUS). We also sought to evaluate the psychosocial impact based on the results of the strategies. Methods: Nested within a randomised pragmatic trial, which compared an immediate colposcopy, repeat Pap-smear, and high risk HPV test, we enrolled 675 women between 2012 and 2014. Participants completed surveys at enrollment, two weeks after triage test results, and 1 year thereafter to assess cervical cancer and HPV knowledge, self-esteem, anxiety and HPV impact (HIP). Results: Knowledge, self-esteem, anxiety and HIP improved with no differences among arms. At the baseline, 31.4% and 32.7% of the participants had state anxiety and trait anxiety, respectively, which decreased to 10.7% and 13.3% in the last survey. Compared to HPV-negative women, HPV-positive women in the second survey had worse HIP scores (HPV-: M 22.9 [SD: 15.20]; HPV+: M 35.9 [SD: 19.91]; p < 0.001), trait anxiety (HPV-: M 15.4 [SD 12.73]; HPV+: M 22.9 [SD 13.29]; p = 0.001), and state anxiety (HPV-: M 10.7 [SD 11.25]; HPV+: M 21.4 [SD 14.81]; p < 0.001). Conclusions: HPV testing as a triage strategy for women with ASCUS does not differ from colposcopies or Pap-smears in terms of psychosocial outcomes.

Comparison of the ATB® Fungus 2 with the AFST-EUCAST for in vitro susceptibility testing of Candida spp

The increase of diseases caused by Candida spp., and the treatment failures, has underscored the need for testing the susceptibilities to antifungal agents. The commercial panel ATB® Fungus 2 was compared with the reference testing method of the European Subcommittee on Antifungal Susceptibility Testing of the Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST) for the evaluation of the susceptibility of isolates of Candida spp. to three agents. The percentage of agreement was calculated based on the minimum inhibitory concentrations. There was a high correlation for AMB (100% қ = 1.0 Bhapkar coefficient p = 1.0); while it was lower with azoles (85%, қ = 0.41, p = Bhapkar coefficient 0.02 and 83.0%, қ = 0.15, Bhapkar coefficient p = 0.0006, respectively). The ATB® Fungus 2 and AFST-EUCAST are fully comparable methods for testing the susceptibility to AMB and to lesser extend comparable for ITR and FCA.

El aumento de infecciones por Candida spp. y de las fallas en los tratamientos, suscitan la necesidad de pruebas de susceptibilidad. Se comparó la marca comercial ATB® Fungus 2 con la técnica estándar del Subcomité para las Pruebas de Sensibilidad Antifúngica de la Unión Europea, de la Sociedad de Microbiología Clínica y Enfermedades Infecciosas (AFST-EUCAST) para evaluar la susceptibilidad de aislamientos de Candida spp. a tres antifúngicos. Con base en las concentraciones inhibitorias mínimas se calculó el porcentaje de acuerdo. La concordancia para anfotericina B (AMB) fue alta (100% қ = 1.0, Coeficiente de Bhapkarp = 1.0); para itraconazol (ITR) y fluconazol (FCA) fue inferior (85% қ = 0.41, Coeficiente de Bhapkarp =0.02 y 83.0 %, қ = 0.15, Coeficiente de Bhapkarp = 0.0006, respectivamente). Por lo tanto, ambas técnicas son comparables para la evaluación de la susceptibilidad a AMB; con los azoles el porcentaje de acuerdo es menor.

Seroprevalencia de babesiosis bovina en la hacienda Vegas de la Clara, Gómez Plata (Antioquia), 2008 / Seroprevalence of bovine babesiosis at the Vegas De La Clara Farm, Gómez Plata (Antioquia), 2008

La babesiosis es una enfermedad del ganado bovino transmitida por la garrapata Rhipicephalus (Boophilus) microplus y causada por los parásitos protozoarios Babesia bovis y B. bigemina. Una zona se considera epizootiológicamente estable frente a Babesia spp, cuando el 75% de los bovinos entre las edades de 3 a 9 meses son serorreactivos (IgG) frente a Babesia bovis y Babesia bigemina y no hay evidencia de signos clínicos. El objetivo de esta investigación fue determinar la seroprevalencia de Babesia bovis y Babesia bigemina en el ganado bovino de la hacienda Vegas de la Clara (Universidad de Antioquia, Gómez Plata, Antioquia), por medio de inmunofluorescencia indirecta. Se diseñó un estudio descriptivo prospectivo con análisis de corte transversal. Fue evaluada toda la población bovina de la hacienda Vegas de la Clara (n = 118). Las muestras fueron evaluadas por inmunofluorescencia indirecta para la detección de anticuerpos tipo IgG específicos contra Babesia bovis y B. bigemina. La serorreactividad obtenida en los bovinos evaluados, para al menos una especie de Babesia fue del 89,8%, para Babesia bovis del 83,8%, mientras que para B. bigemina del 61%. Se obtuvo una relación estadísticamente significativa entre la serorreactividad para B. bigemina y la frecuencia del tratamiento garrapaticida. La serorreactividad indica estabilidad enzoótica en el hato para B. bovis, mientras que para B. bigemina se encontró que la frecuencia del tratamiento garrapaticida interrumpe su ciclo de transmisión.

Babesiosis is a cattle disease transmitted by Rhipicephalus (Boophilus) microplus ticks and caused by protozoan parasites Babesia bovis and Babesia bigemina. An area is considered as epizootiologically stable to Babesia spp when 75% of the cattle between the ages of 3 to 9 months are seroreactive (IgG) against Babesia bovis and Babesia bigemina, and there is no clinical evidence. The purpose of this study was to determine the seroprevalence of Babesia bovis and Babesia bigemina in cattle at the Vegas de la Clara Farm (Antioquia University, Gómez Plata, Antioquia) through indirect immunofluorescence. A prospective descriptive study with cross-sectional analysis was designed and the entire bovine population of the Clara Vegas Farm (n = 118) was evaluated. All samples were evaluated through indirect immunofluorescence in order to detect specific IgG antibodies against B. bovis and B. bigemina. The seroreactivity obtained in the evaluated bovines for at least one species of Babesia was of 89.8%, of 83.8% for Babesia bovis and of 61% for B. bigemina. A statistically significant relationship was obtained between the seroreactivity for B. bigemina and the frequency of acaricide treatment. Seroreactivity indicates enzootic stability in the herd for B. bovis, whereas for B. bigemina it was found that the frequency of acaricide treatment interrupts its transmission cycle.